AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,529,133 | -38.4% | 582,900 | -23.3% | 0.01% | -36.8% |
| Q2 2023 | $7,357,768 | +132.9% | 760,100 | +163.6% | 0.02% | +137.5% |
| Q1 2023 | $3,159,768 | +823.5% | 288,300 | +264.0% | 0.01% | +700.0% |
| Q4 2022 | $342,144 | -29.2% | 79,200 | +23.4% | 0.00% | 0.0% |
| Q3 2022 | $483,000 | -42.3% | 64,200 | +13.0% | 0.00% | -50.0% |
| Q3 2020 | $837,000 | -40.9% | 56,800 | -34.9% | 0.00% | -50.0% |
| Q2 2020 | $1,417,000 | +32.3% | 87,200 | +18.2% | 0.00% | 0.0% |
| Q1 2020 | $1,071,000 | +1408.5% | 73,800 | +577.1% | 0.00% | – |
| Q1 2019 | $71,000 | -51.4% | 10,900 | -57.9% | 0.00% | – |
| Q2 2018 | $146,000 | -25.9% | 25,900 | -31.7% | 0.00% | -100.0% |
| Q1 2018 | $197,000 | -10.0% | 37,900 | -21.7% | 0.00% | 0.0% |
| Q4 2017 | $219,000 | -37.1% | 48,400 | -12.8% | 0.00% | 0.0% |
| Q3 2017 | $348,000 | +21.7% | 55,500 | +19.1% | 0.00% | 0.0% |
| Q2 2017 | $286,000 | – | 46,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |